From Single Target to Multitarget/Network Therapeutics in Alzheimer's Therapy
Brain network dysfunction in Alzheimer's disease (AD) involves many proteins (enzymes), processes and pathways, which overlap and influence one another in AD pathogenesis. This complexity challenges the dominant paradigm in drug discovery or a single-target drug for a single mechanism. Although...
Saved in:
Main Authors: | Hailin Zheng (Author), Mati Fridkin (Author), Moussa Youdim (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer's Disease
by: Márcia Martins, et al.
Published: (2020) -
Study of the multitarget mechanism of Astragalus (HUANGQI) in the treatment of Alzheimer's disease based on network pharmacology and molecular docking technology
by: Feng Lv, et al.
Published: (2024) -
Multitarget Therapy: An Effective and Safe Therapeutic Regimen for Lupus Nephritis
by: Tianbiao Zhou, et al.
Published: (2019) -
Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's disease
by: Donia E. Hafez, et al.
Published: (2023) -
Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease
by: Wen-Yu Wu, et al.
Published: (2017)